SAB BIOTHERAPEUTICS, INC. (SABS) Operating margin 2020–2024
SAB BIOTHERAPEUTICS, INC. (SABS) operating margin by fiscal year — reported operating income divided by reported revenue.
-3244.9%FY2024 · since FY2020: 37.2% → -3244.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -3244.9% | -1544.3 pp |
| FY2023 | -1700.6% | -1579.6 pp |
| FY2022 | -121.0% | -99.0 pp |
| FY2021 | -22.0% | -59.2 pp |
| FY2020 | 37.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SABS financial trends
SABS RevenueSABS Net incomeSABS Net marginSABS Gross profitSABS Gross marginSABS Operating incomeSABS Operating cash flowSABS Free cash flowSABS Capital expendituresSABS Return on equitySABS Stock buybacksSABS Dividends paidSABS Total assetsSABS Total liabilitiesSABS Shareholders’ equitySABS overview →